Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Dick

Showing results (171-180 of 178) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 178 results.
Tuberculosis (Edinburgh, Scotland)|July 24, 2012
Detection and treatment of subclinical tuberculosisBrian D Robertson, Danny Altmann, Clif Barry, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2008
Peptide deformylase inhibitors of Mycobacterium tuberculosis: synthesis, structural investigations, and biological resultsArkadius Pichota, Jeyaraj Duraiswamy, Zheng Yin, et al.
ACS Chemical Biology|April 17, 2012
A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosisPuiying A Mak, Srinivasa P S Rao, Mai Ping Tan, et al.
American Journal of Respiratory and Critical Care Medicine|November 15, 2018
Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for ResearchShelby Daniel-Wayman, Getahun Abate, Daniel L Barber, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2025
Next-generation rifamycins for the treatment of mycobacterial infectionsVéronique Dartois, Tian Lan, Uday S Ganapathy, et al.
ACS Infectious Diseases|January 27, 2023
Synthesis and Testing of Analogs of the Tuberculosis Drug Candidate SQ109 against Bacteria and Protozoa: Identification of Lead Compounds against <i>Mycobacterium abscessus</i> and Malaria ParasitesMarianna Stampolaki, Satish R Malwal, Nadine Alvarez-Cabrera, et al.
Science Translational Medicine|December 6, 2013
Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosisSrinivasa P S Rao, Suresh B Lakshminarayana, Ravinder R Kondreddi, et al.
Nature Communications|October 27, 2010
A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacyKevin Pethe, Patricia C Sequeira, Sanjay Agarwalla, et al.
Pageof 18

Showing results (171-180 of 178) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 178 results.
Tuberculosis (Edinburgh, Scotland)|July 24, 2012
Detection and treatment of subclinical tuberculosisBrian D Robertson, Danny Altmann, Clif Barry, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2008
Peptide deformylase inhibitors of Mycobacterium tuberculosis: synthesis, structural investigations, and biological resultsArkadius Pichota, Jeyaraj Duraiswamy, Zheng Yin, et al.
ACS Chemical Biology|April 17, 2012
A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosisPuiying A Mak, Srinivasa P S Rao, Mai Ping Tan, et al.
American Journal of Respiratory and Critical Care Medicine|November 15, 2018
Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for ResearchShelby Daniel-Wayman, Getahun Abate, Daniel L Barber, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2025
Next-generation rifamycins for the treatment of mycobacterial infectionsVéronique Dartois, Tian Lan, Uday S Ganapathy, et al.
ACS Infectious Diseases|January 27, 2023
Synthesis and Testing of Analogs of the Tuberculosis Drug Candidate SQ109 against Bacteria and Protozoa: Identification of Lead Compounds against <i>Mycobacterium abscessus</i> and Malaria ParasitesMarianna Stampolaki, Satish R Malwal, Nadine Alvarez-Cabrera, et al.
Science Translational Medicine|December 6, 2013
Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosisSrinivasa P S Rao, Suresh B Lakshminarayana, Ravinder R Kondreddi, et al.
Nature Communications|October 27, 2010
A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacyKevin Pethe, Patricia C Sequeira, Sanjay Agarwalla, et al.
Pageof 18